Dresden in focus: Radiopharmacy Forum strengthens Saxony's health network

Dresden in focus: Radiopharmacy Forum strengthens Saxony's health network

The Hi-Tech-meets Life Sciences Forum, which is entirely dedicated to radiopharmacy, is currently taking place in the Saxon state capital of Dresden. Under the motto “Expand value creation – strengthen the radiopharmacy ecosystem in Saxony” over 120 participants from science, industry, clinics and networks will gather. This is an exciting opportunity to discuss the latest developments and challenges in radiopharmacy. A report from Media service Saxony emphasizes that the first day of the event is packed with specialist lectures. The focus is on topics such as the production of clinically relevant radionuclides and the development and approval of radiopharmaceuticals.

A special highlight is the presentation of the Belgian radiopharmacy cluster Rad4Med.be, which serves as an example of successful international cooperation. The European Organization for Nuclear Research (CERN) will also present its exciting research. Networking opportunities and formats such as a talk show entitled “Hot Spot Saxony – How radiopharmacy finds a home here” offer exchange and the opportunity to make valuable contacts.

The second day of the event

The second day of the forum is characterized by an industry tour that gives participants insights into the laboratories and production facilities. Visits to well-known institutions such as ABX advanced biochemical compounds, NCT Dresden and TRIMT GmbH are planned. This makes it clear how the Saxon economy is structured and what patient care looks like in this area.

Radiopharmacy is a key technology in cancer treatment. Around 500,000 people in Germany are affected by cancer every year, and as the number of patients increases, the need for innovative approaches becomes ever greater. Advances in diagnostics and therapy have been made in recent years, but the need for state-of-the-art technology remains unbroken. daily news reports that artificial intelligence (AI) in cancer medicine has potential to optimize treatments and improve the quality of diagnoses.

Use of AI in radiopharmacy

Artificial intelligence could particularly help doctors analyze a wide range of image data. Radiologist David Bonekamp emphasizes that evaluating 6,000 to 8,000 images per patient is a huge challenge. AI systems can make this task more efficient and thus enable faster, more accurate diagnoses. An algorithm for assessing magnetic resonance images in prostate cancer is already showing initial promising results and could make biological examinations unnecessary in the future.

The event is organized by the Hi-Tech Forum of the Helmholtz Center Dresden-Rossendorf (HZDR) and the Life Sciences Forum of the Sachsen Economic Development GmbH (WFS). Another crucial point is the recent establishment of the nukliD Radiopharmacy Cluster in Dresden, which aims to position Saxony as a center for innovation in radiopharmacy. Both research and industry can benefit from solid networking.

The strengthening of Saxon radiopharmacy is also supported by modern infrastructure at the HZDR, which underlines the scientific excellence of the region. The feedback from the first round of events shows that the synergy effects of the meetings are noticeable. It remains exciting to see how Saxony will develop as a leading center for radiopharmacy and research. Find out more about radiopharmacy and future opportunities in Saxony on the website Location Saxony.